Sun Pharma to sell Ranbaxys 2 CNS divisions to Strides for Rs 165 cr
Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxys two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore. Sun Pharma and Strides... Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated September 19, 2015 titled "Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy". Sun Pharma to acquire InSite Vision
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated September 15, 2015 titled "Sun Pharma to acquire InSite Vision".
Sun Pharma in the running to acquire InSite Vision?
Earlier in August, InSite Vision announced a definite agreement with drug firm QLT IPM touches Rs. 96,372 crores in August, growth of 14 per cent: IMS Health
Sun Pharma,with market share of 8.01 per cent, continues to top the chartsSUN PHARMA LTD.
tax credit of Rs 600cr. Thus, adjusted for merger related expenses, the Adj. PAT came in at Rs 1,622cr, posting a yoy growth of 2.2% vScore: vScore (Value Score) is our proprietary company rating system f Strongest ANDA pipeline: Sun Pharma, with the recent acquisitions of DUSA, URL Pharma and Ranbaxy Laboratories, has now become strong in the US region, with the geography accounting for 50% of its sales in FY2015. In terms of ANDAs, the company cumulatively has 438 products as of March 2015. As of... India Inc's Overseas Investment Up 58% at $2.19 Billion in August
Sun Pharmaceutical Industries $455 million in a joint venture in Mauritius, Biocon Ltd a total of $440.04 million in two separate tranches in a wholly owned unit in UAE and a joint venture in Malaysia... Sun Pharmaceutical Industries Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing in Reuters Website on September 10, 2015 titled "Sun Pharma looking to divest Ireland plant" Sun Pharmaceutical Industries Ltd replied stating "We hereby confirm that following Sun Pharma's successful completion of Ranbaxy merger, there is an opportunity to optimize overall manufacturing network. As a result, decisions are being... Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing on Reuters Website on September 10, 2015 titled "Sun Pharma looking to divest Ireland plant" The reply is awaited.
Sun Pharma planning to divest Ireland plant to cut costs
Decisions are being made to either close or divest some of the manufacturing facilities, the spokesperson said